Endogenous Peptide
Also known as: Natural peptide, Naturally occurring peptide, Native peptide
Endogenous Peptide refers to a peptide that is naturally produced within the body. Endogenous peptides serve as hormones, neurotransmitters, growth factors, and signaling molecules. Understanding endogenous peptides helps contextualize research on synthetic peptide analogs designed to mimic or modify their effects.
Last updated: January 28, 2026
What is an Endogenous Peptide?
An endogenous peptide is any peptide naturally produced by the body. The human body makes thousands of different peptides that regulate virtually every physiological process—from metabolism and growth to mood and immune function.
Key concept: Many synthetic peptides in research are designed to mimic, enhance, or block the effects of endogenous peptides.
How Endogenous Peptides Are Made
Biosynthesis pathway:
DNA → mRNA → Precursor protein → Enzymatic cleavage → Active peptide- Transcription: Gene encodes a larger precursor protein
- Translation: Precursor protein synthesized on ribosomes
- Processing: Enzymes cleave precursor into active peptides
- Modification: Post-translational modifications may occur
- Secretion: Peptide released to act on target cells
Major Categories of Endogenous Peptides
| Category | Examples | Functions |
|---|---|---|
| Hormones | Insulin, GLP-1, GH | Metabolic regulation |
| Neuropeptides | Endorphins, NPY | Neural signaling |
| Growth factors | IGF-1, EGF | Cell growth, repair |
| Antimicrobial | LL-37, defensins | Immune defense |
| Cytokines | Interleukins | Immune regulation |
Examples: Endogenous vs Synthetic
| Endogenous Peptide | Synthetic Analog | Purpose of Modification |
|---|---|---|
| GLP-1 | Semaglutide | Longer half-life |
| GHRH | Sermorelin | Therapeutic use |
| GHK | GHK-Cu | Enhanced stability |
| Thymosin α1 | Synthetic Ta1 | Standardized production |
| BPC (gastric) | BPC-157 (fragment) | Research applications |
Why Endogenous Peptides Need Modification
Natural peptides often have limitations for therapeutic use:
| Limitation | Solution in Synthetic Analogs |
|---|---|
| Short half-life | Amino acid substitutions, fatty acid chains |
| Poor oral absorption | Formulation technologies (SNAC) |
| Rapid degradation | D-amino acids, cyclization |
| Low potency | Sequence optimization |
Example: Natural GLP-1 has a half-life of 1-2 minutes. Semaglutide, through modifications, has a half-life of ~1 week.
Key Endogenous Peptides in Research Context
Metabolic Peptides
| Peptide | Source | Role |
|---|---|---|
| GLP-1 | Intestinal L-cells | Insulin, appetite |
| GIP | Intestinal K-cells | Insulin, fat metabolism |
| Ghrelin | Stomach | Appetite, GH release |
| Insulin | Pancreatic β-cells | Glucose uptake |
Growth and Repair
| Peptide | Source | Role |
|---|---|---|
| Growth hormone | Pituitary | Growth, metabolism |
| IGF-1 | Liver (mainly) | Cell growth |
| Thymosin β4 | Many cells | Wound healing |
| GHK | Various tissues | Tissue remodeling |
Neuropeptides
| Peptide | Source | Role |
|---|---|---|
| Endorphins | Pituitary, CNS | Pain, pleasure |
| Oxytocin | Hypothalamus | Bonding, labor |
| Vasopressin | Hypothalamus | Water balance |
Endogenous Peptide Research
Understanding endogenous peptides informs peptide research:
- Mechanism studies: How do natural peptides work?
- Biomarker research: Do levels correlate with disease?
- Drug design: Can we improve on nature?
- Receptor mapping: Where do peptides act?
Clinical Relevance
| Condition | Endogenous Peptide Involved |
|---|---|
| Type 2 diabetes | GLP-1 (deficient signaling) |
| Growth disorders | Growth hormone, IGF-1 |
| Obesity | GLP-1, ghrelin, NPY |
| Chronic pain | Endorphins |
| Immune deficiency | Thymic peptides |
This entry is for educational purposes only. Understanding endogenous peptides provides context for peptide research.
Related Peptides
Related Terms
Disclaimer: This glossary entry is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for medical questions.